| 1 | Technology | XLK | +28.1% |
| 2 | Energy | XLE | +26.1% |
| 3 | Materials | XLB | +13.1% |
| 4 | Real Estate | XLRE | +12.3% |
| 5 | Industrials | XLI | +11.5% |
| 6 | Consumer Staples | XLP | +10.5% |
| 7 | Utilities | XLU | +3.1% |
| 8 | Healthcare | XLV | -1.1% |
| 9 | Consumer Disc. | XLY | -1.5% |
| 10 | Financials | XLF | -2.9% |
| 11 | Communication | XLC | -4.5% |
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q2 '26 | 5/7/26 | $-1.14 | $-0.93 | +18.4% | -134% | $0.1B | $0.1B | +6.5% | -86% |
| Q1 '26 | 2/5/26 | $0.02 | $0.22 | +10.0% | +116% | $0.3B | $0.3B | +2.9% | +10461% |
| Q4 '25 | 11/25/25 | $-0.05 | $-0.18 | -2.6% | +87% | $0.2B | $0.3B | +46.1% | — |
| Q3 '25 | 8/7/25 | $-1.04 | $-1.26 | -21.1% | +9% | $0.0B | $0.0B | -17.8% | — |
| Q2 '25 | 5/12/25 | $-0.46 | $2.75 | +7.0% | +370% | $0.1B | $0.5B | +3.7% | — |